Leukemia
ASCO 2022: Crenolanib Combined With Chemotherapy in Newly Diagnosed FLT3-Mutant AML
You're currently viewing OncGenius as a guest. To save your results, create an account or log in.
Advertisement
Advertisement
ASCO 2022: Crenolanib Combined With Chemotherapy in Newly Diagnosed FLT3-Mutant AML
ASCO 2022: New Data on IDH2-Mutant Alleles and Endasidenib in AML
ASCO 2022: Measurable Residual Disease Testing as Prognostic Tool in Acute Myeloid Leukemia
Addition of Ivosidenib to Azacitidine in Newly Diagnosed IDH1-Mutated AML